Impaired up-Regulation of Polo-Like Kinase 2 (PLK2) during Fludarabine- and 2-Chlorodeoxyadenosine (CdA)-Induced Cell Killing in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Lymphocytes: A Potential Marker of Defective Damage Response

被引：0
|
作者：
de Viron, Emeline [1 ]
Knoops, Laurent [2 ,3 ]
Connerotte, Thierry [3 ]
Smal, Caroline [1 ]
Michaux, Lucienne [3 ]
Saussoy, Pascale [3 ]
Bontemps, Francoise [1 ]
Van Den Neste, Eric [3 ]
机构：
[1] de Duve Inst, Physiol Chem Lab, Brussels, Belgium
[2] UCL, de Duve Inst, Brussels, Belgium
[3] Clin Univ St Luc, B-1200 Brussels, Belgium
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 16 条
  • [1] Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response
    de Viron, Emeline
    Knoops, Laurent
    Connerotte, Thierry
    Smal, Caroline
    Michaux, Lucienne
    Saussoy, Pascale
    Vannuffel, Pascal
    Beert, Eline
    Vekemans, Marie-Christiane
    Hermans, Cedric
    Bontemps, Francoise
    Van Den Neste, Eric
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (05) : 641 - 652
  • [2] 2-chlorodeoxyadenosine (2-CdA) in the treatment of patients with B-cell chronic lymphocytic leukemia (B-CLL) aged 70 years and older.
    Robak, T
    Blasinska-Morawiec, M
    Blonski, JZ
    BLOOD, 1998, 92 (10) : 282B - 282B
  • [3] RESPONSE TO 2-CHLORODEOXYADENOSINE IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO FLUDARABINE
    JULIUSSON, G
    ELMHORNROSENBORG, A
    LILIEMARK, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15): : 1056 - 1061
  • [4] 2-CHLORODEOXYADENOSINE FOR PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO FLUDARABINE
    DELANNOY, A
    HANIQUE, G
    FERRANT, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (11): : 812 - 812
  • [5] 2-chlorodeoxyadenosine (2-CdA) and prednisone (P) versus chlorambucil (Chl) and prednisone as a first line therapy in B-cell chronic lymphocytic leukemia (B-CLL).
    Robak, T
    BlasinskaMorawiec, M
    Blonski, JZ
    Krykowski, E
    Dmoszynska, A
    Skotnicki, AB
    Konopka, L
    Hellmann, A
    Kuratowska, Z
    Urasinski, I
    KotlarekHaus, S
    Maj, S
    BLOOD, 1997, 90 (10) : 2361 - 2361
  • [6] 2-CHLORODEOXYADENOSINE FOR PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO FLUDARABINE - REPLY
    JULIUSSON, G
    LILIEMARK, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (11): : 813 - 813
  • [7] Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
    Syed, N
    Smith, P
    Sullivan, A
    Spender, LC
    Dyer, M
    Karran, L
    O'Nions, J
    Allday, M
    Hoffmann, I
    Crawford, D
    Griffin, B
    Farrell, PJ
    Crook, T
    BLOOD, 2006, 107 (01) : 250 - 256
  • [8] Treatment of B-Cell chronic lymphocytic leukaemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) given by 2-hours infusions
    Robak, T
    BlasinskaMorawiec, M
    Krykowski, E
    Pluzanska, A
    Hellmann, A
    Dmoszynska, A
    Hansz, J
    Komarnicki, M
    Konopka, L
    KotlarekHaus, S
    Urasinski, J
    Skotnicki, AB
    Kuratowska, Z
    Grieb, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 459 - 459
  • [9] 2-CHLORODEOXYADENOSINE FOR PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO FLUDARABINE (VOL 328, PG 812, 1993)
    SAVEN, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24): : 1796 - 1796
  • [10] 2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia
    Robak, T
    SysaJedrzejowska, A
    Robak, E
    Dabkowski, J
    BlasinskaMorawiec, M
    JOURNAL OF MEDICINE, 1997, 28 (3-4) : 199 - 209
12